These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35235173)

  • 21. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension.
    Hartman PJ; Cooke DL; Hsu HH; Stewart J; Sumi K; Yoshida Y; Hidaka H; Novack GD
    Ophthalmol Glaucoma; 2023; 6(2):198-205. PubMed ID: 36055467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
    Shedden A; Laurence J; Tipping R;
    Clin Ther; 2001 Mar; 23(3):440-50. PubMed ID: 11318078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension.
    Hartenbaum D; Maloney S; Vaccarelli L; Liss C; Wilson H; Gormley GJ
    Clin Ther; 1999 Sep; 21(9):1533-8. PubMed ID: 10509848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.
    Ackerman SL; Torkildsen GL; McLaurin E; Vittitow JL
    Clin Exp Optom; 2019 Mar; 102(2):131-139. PubMed ID: 30525235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a 0.9% sodium chloride ophthalmic solution on the ocular surface of symptomatic contact lens wearers.
    Barabino S; Rolando M; Camicione P; Chen W; Calabria G
    Can J Ophthalmol; 2005 Feb; 40(1):45-50. PubMed ID: 15825529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison study between pilocarpine and tropicamide drops on corneal topography and their effect on IL-6 and TNF-α levels in tear.
    Zhang Y; Zhao J
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):73-78. PubMed ID: 36227674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: a single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis.
    Torkildsen GL; Abelson MB; Gomes PJ
    Clin Ther; 2008 Jul; 30(7):1272-82. PubMed ID: 18691986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
    Iyer GR; Cason MM; Womble SW; Li G; Chastain JE
    J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and tolerability of 2 presentations of eyedrops combining carteolol 2% and pilocarpine 2% in primary open-angle glaucoma and simple ocular hypertension].
    Sirbat D; Charlin JF; Cohn H; Dascotte JC; George JL; Lesure P; Massin M; Massin G; Maurin JF; Renard JP
    J Fr Ophtalmol; 1995; 18(10):589-96. PubMed ID: 8568162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model.
    Butrus S; Greiner JV; Discepola M; Finegold I
    Clin Ther; 2000 Dec; 22(12):1462-72. PubMed ID: 11192137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varenicline Solution Nasal Spray: A Review in Dry Eye Disease.
    Frampton JE
    Drugs; 2022 Sep; 82(14):1481-1488. PubMed ID: 36197638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects.
    Malhotra RP; Meier E; Torkildsen G; Gomes PJ; Jasek MC
    Clin Ophthalmol; 2019; 13():403-413. PubMed ID: 30858690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial.
    Korenfeld MS; Robertson SM; Stein JM; Evans DG; Rauchman SH; Sall KN; Venkataraman S; Chen BL; Wuttke M; Burns W
    Eye (Lond); 2021 Dec; 35(12):3292-3301. PubMed ID: 33514891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops.
    Mazor Z; Ticho U; Rehany U; Rose L
    Br J Ophthalmol; 1979 Jan; 63(1):48-51. PubMed ID: 367431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial.
    Nichols KK; Holland E; Toyos MM; Peace JH; Majmudar P; Raychaudhuri A; Hamdani M; Roy M; Shojaei A
    Clin Ophthalmol; 2018; 12():263-270. PubMed ID: 29440868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
    Andermann C; Mialhe D; Arne JL; Vende D; Bec P
    J Fr Ophtalmol; 1983; 6(4):367-74. PubMed ID: 6350412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilocarpine 1.25% Ophthalmic Solution (Vuity) for the Treatment of Presbyopia.
    Tucker T; Early J
    Am Fam Physician; 2023 Jun; 107(6):659-660. PubMed ID: 37327177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.